Observational studyInternational journal of urology : official journal of the Japanese Urological Association2025

The Effectiveness and Safety Profile of Nivolumab-Plus-Ipilimumab in Previously Untreated Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma (J-ENCORE Study).

Koshiro Nishimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.